[1]
“Intervention by clinical pharmacist targeting Nonalcoholic Steatohepatitis induced by Tamoxifen”, AJPHS, vol. 13, no. 3, pp. 2869–2871, Sep. 2023, doi: 10.5530/4mn6r918.